|
| Press Releases |
|
 |
|
| Tuesday, August 13, 2013 |
|
|
New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine |
| A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). more info >> |
|
| Tuesday, August 6, 2013 |
|
|
Unexpected Synergy Between Two Cancer-linked Proteins Offers Hope for Personalised Cancer Therapy |
| A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. more info >> |
|
| Saturday, July 27, 2013 |
|
|
Singapore Scientists Discover New Drug Targets for Aggressive Breast Cancer |
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS.
more info >> |
|
| Tuesday, July 2, 2013 |
|
|
Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells |
| Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. more info >> |
|
| Friday, May 17, 2013 |
|
|
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >> |
|
| Thursday, April 25, 2013 |
|
|
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases |
| The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop(TM), the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. more info >> |
|
| Monday, April 22, 2013 |
|
|
Understanding Abnormal Proteins in Degenerative Diseases |
| Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding abnormal proteins, providing them with the insights required to design more effective treatments for degenerative diseases such as Alzheimer's, diabetes and cancer. more info >> |
|
| Thursday, April 18, 2013 |
|
|
Singapore Scientist Wins Coveted Chen New Investigator Award 2013 |
| Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). more info >> |
|
|
A*STAR Scientists Decipher Genome Code of a Living Fossil |
| An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land. more info >> |
|
| Friday, April 5, 2013 |
|
|
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research |
| Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Paying Off Debt but Still Want to Save? Here's How to Manage Both
May 18, 2026 23:30 HKT/SGT
|
|
|
DK88 Launches New Online iGaming App for Malaysia and Singapore
May 18, 2026 22:40 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 18, 2026 21:52 HKT/SGT
|
|
|
Carbonverse Pioneers a New Ecosystem of "Carbon Assets + Digital Wallet + Use-to-Earn"
May 18, 2026 21:45 HKT/SGT
|
|
|
Carbonverse打造「碳资产+数字钱包+使用即挖矿」新生态
May 18, 2026 21:45 HKT/SGT
|
|
|
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
May 18, 2026 21:37: JST
|
|
|
「吉普賽之王」泰森·富里加入 Datavault AI 擔任國際代言人，致力推動運動員數據變現
May 18, 2026 20:37 HKT/SGT
|
|
|
“吉普赛之王”泰森·富里加盟Datavault AI，担任国际形象大使，致力于推动运动员数据变现
May 18, 2026 20:37 HKT/SGT
|
|
|
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
May 18, 2026 20:37 HKT/SGT
|
|
|
'Hong Kong Cinema @ CANNES 2026': Hong Kong's role as a bridge between global and Asian film markets
May 18, 2026 19:19: JST
|
|
|
Ashikaga Bank launches Fujitsu's service supporting digitalization of Inheritance Procedure
May 18, 2026 18:13 JST
|
|
|
Sharp to Exhibit at The 3rd SPEXA - Space Business Expo
May 18, 2026 17:34 JST
|
|
|
Your Go-To Travel Checklist for Smarter, Reward-Focused Travel Planning
May 18, 2026 16:32 HKT/SGT
|
|
|
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform
May 18, 2026 16:30 HKT/SGT
|
|
|
MHIEC Receives Waste Treatment Technology Verification Report from JESC for Its Fluidized Bed-type Gasification and Reforming System
May 18, 2026 17:17 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
